CARsgen Therapeutics Holdings Limited (2171.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.36B |
| Enterprise Value | 6.3B |
| P/E Ratio | -72.28 |
| PEG Ratio | -0.71 |
| Price/Sales Ratio | 48.69 |
| Price/Book Ratio | 5.86 |
| Enterprise/Revenue | 38.91 |
| Enterprise/EBITDA | -27.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.65 |
| Operating Margin | -1.2 |
AD
Management Effectiveness
| Return On Assets | -0.06 |
| Return On Equity | -0.09 |
Income Statement
| Revenue | 125.66M |
| Revenue/Share | 0.25 |
| Gross Profit | 79.95M |
| EBITDA | -203.91M |
| Net Income | -97.86M |
| Diluted EPS | -0.18 |
Balance Sheet
| Total Cash | 1.4B |
| Total Cash/Share | 2.54 |
| Total Debt | 71.98M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 7.07 |
| Book Value Per Share | 1.98 |
Price History
| 52-Week Change | -36 |
| 52-Week High | 28.6 |
| 52-Week Low | 10.87 |
| Moving Average 50 Days | 14.87 |
| Moving Average 200 Days | 16.54 |
Statistics
| Average Volume | 4.99M |
| Shares Outstanding | 569.83M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
